102 related articles for article (PubMed ID: 36654702)
1. Use of an Innovative Pharmaceutical Class Scoring Tool for Prioritized Annual Formulary Review.
Sheldon H; Kostrzewa A; Werner S; Audley T; Biggs A; Mancuso T; Picone MF
Innov Pharm; 2022; 13(2):. PubMed ID: 36654702
[No Abstract] [Full Text] [Related]
2. From a to z: medication cost-management strategies for disproportionate share hospitals.
Henry A; Erowele GI; Ndefo UA; Milton-Brown J; Anassi E; Green W; Alvidrez A; Okpara AU
Am Health Drug Benefits; 2011 May; 4(3):172-80. PubMed ID: 25126349
[TBL] [Abstract][Full Text] [Related]
3. Formulary evaluation using a class review approach: experience and results from an academic medical center.
Persson EL; Miller KS; Nieman JA; Sgourakis AP; Akkerman SR
P T; 2013 Apr; 38(4):213-6. PubMed ID: 23785226
[TBL] [Abstract][Full Text] [Related]
4. P&T Committee Drug Prioritization Criteria: A Tool Developed by a Saudi Health Care System.
Esba LCA; Almodaimegh H; Alhammad A; Ferwana M; Yousef C; Ismail S
P T; 2018 May; 43(5):293-300. PubMed ID: 29719371
[TBL] [Abstract][Full Text] [Related]
5. Expediting Formulary Standardization in a Multihospital Health System Using Layered Learners.
Hays AJ; Smith JR; Guth RM; Samet SE
P T; 2018 Mar; 43(3):163-167. PubMed ID: 29491699
[TBL] [Abstract][Full Text] [Related]
6. Impact of a transition to more restrictive drug formulary on therapy discontinuation and medication adherence.
Shirneshan E; Kyrychenko P; Matlin OS; Avila JP; Brennan TA; Shrank WH
J Clin Pharm Ther; 2016 Feb; 41(1):64-9. PubMed ID: 26778812
[TBL] [Abstract][Full Text] [Related]
7. Aligning Formulary Restrictions Across a Health System and Improving Access to and Clarity of Medication Restrictions.
Solano S; Dow J; Audley T; Bangalore N
P T; 2019 Jan; 44(2):64-68. PubMed ID: 30766012
[TBL] [Abstract][Full Text] [Related]
8. Impact of Modified System of Objectified Judgement Analysis (SOJA) methodology on prescribing costs of ACE inhibitors.
Alabbadi I; Crealey G; Scott M; Baird S; Trouton T; Mairs J; McElnay J
Clin Drug Investig; 2006; 26(9):485-94. PubMed ID: 17163281
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of angiotensin II receptor blockers for drug formulary using objective scoring analytical tool.
Lim TM; Ibrahim MI
Pharm Pract (Granada); 2012 Jul; 10(3):136-42. PubMed ID: 24155829
[TBL] [Abstract][Full Text] [Related]
10. A bitter pill: formulary variability and the challenge to prescribing physicians.
Shrank WH; Ettner SL; Glassman P; Asch SM
J Am Board Fam Pract; 2004; 17(6):401-7. PubMed ID: 15575031
[TBL] [Abstract][Full Text] [Related]
11. Application of pharmacoeconomics to formulary management in a health system setting.
Studdert AL; Gong CL; Srinivas S; Chin AL; Deresinski S
Am J Health Syst Pharm; 2019 Feb; 76(6):381-386. PubMed ID: 31361838
[TBL] [Abstract][Full Text] [Related]
12. Review of Nonformulary Medication Approvals in an Academic Medical Center.
Her QL; Amato MG; Seger DL; Gilmore JF; Fanikos J; Fiskio JM; Bates DW
Jt Comm J Qual Patient Saf; 2017 Feb; 43(2):89-96. PubMed ID: 28334567
[TBL] [Abstract][Full Text] [Related]
13. Assessment of a hybrid decision support system using machine learning with artificial intelligence to safely rule out prescriptions from medication review in daily practice.
Levivien C; Cavagna P; Grah A; Buronfosse A; Courseau R; Bézie Y; Corny J
Int J Clin Pharm; 2022 Apr; 44(2):459-465. PubMed ID: 34978662
[TBL] [Abstract][Full Text] [Related]
14. The formulary decision-making process in a US academic medical centre.
Nash DB; Catalano ML; Wordell CJ
Pharmacoeconomics; 1993 Jan; 3(1):22-35. PubMed ID: 10146985
[TBL] [Abstract][Full Text] [Related]
15. Factors that influence prescribing decisions.
Schumock GT; Walton SM; Park HY; Nutescu EA; Blackburn JC; Finley JM; Lewis RK
Ann Pharmacother; 2004 Apr; 38(4):557-62. PubMed ID: 14966259
[TBL] [Abstract][Full Text] [Related]
16. Impact of a change of bronchodilator medications in a hospital drug formulary on intra- and out-of-hospital drug prescriptions: interrupted time series design with comparison group.
Vázquez-Mourelle R; Carracedo-Martínez E; Figueiras A
Implement Sci; 2020 May; 15(1):33. PubMed ID: 32410686
[TBL] [Abstract][Full Text] [Related]
17. INTEGRATING HEALTH TECHNOLOGY ASSESSMENT PRINCIPLES IN FORMULARY MANAGEMENT.
Teng M; Khoo AL; Zhao YJ; Lin L; Lim BP
Int J Technol Assess Health Care; 2016 Jan; 32(1-2):81-7. PubMed ID: 27001376
[TBL] [Abstract][Full Text] [Related]
18. Formulary evaluation of third-generation cephalosporins using decision analysis.
Cano SB; Fujita NK
Am J Hosp Pharm; 1988 Mar; 45(3):566-9. PubMed ID: 3285673
[TBL] [Abstract][Full Text] [Related]
19. Implications of an SSRI generic step therapy pharmacy benefit design: an economic model in anxiety disorders.
Panzer PE; Regan TS; Chiao E; Sarnes MW
Am J Manag Care; 2005 Oct; 11(12 Suppl):S370-9. PubMed ID: 16236019
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive pharmaceutical services for a state correctional facility.
Kingston RL; Pfeifle CE; Cipolle RJ; Zaske DE; Eells CB; Johnson HL
Am J Hosp Pharm; 1982 Jan; 39(1):86-9. PubMed ID: 7055154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
